Changeflow GovPing Healthcare & Life Sciences Cells Resistant to Mobile Genetic Elements
Routine Notice Added Final

Cells Resistant to Mobile Genetic Elements

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

USPTO published patent application US20260109938A1, filed July 19, 2023, covering cells resistant to mobile genetic elements and methods for obtaining them. The invention includes orthogonal genetic code systems designed to prevent horizontal gene transfer, with potential applications in protecting engineered cells and preventing unwanted genetic exchange. Inventors are Jason CHIN, Jerome ZURCHER, and Wesley ROBERTSON.

“Provided are cells that are resistant to mobile genetic elements or horizontal gene transfer, and methods for obtaining said cells.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 264 changes logged to date.

What changed

USPTO published patent application US20260109938A1 on April 23, 2026, for cells resistant to mobile genetic elements and methods of obtaining such cells. The application covers new genetic code schemes and orthogonal systems designed to prevent horizontal transfer of genetic information. CPC classifications span C12N (microbiology), C12P (fermentation), and C12R (microorganism classification).

Biotechnology manufacturers and pharmaceutical companies developing engineered cells should monitor this application for competitive intelligence on orthogonal genetic code approaches. While patent applications do not create immediate compliance obligations, they signal emerging technologies in genetic engineering that may inform future research and development strategies.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

GENETIC CODES

Application US20260109938A1 Kind: A1 Apr 23, 2026

Inventors

Jason CHIN, Jerome ZURCHER, Wesley ROBERTSON

Abstract

Provided are cells that are resistant to mobile genetic elements or horizontal gene transfer, and methods for obtaining said cells. Also provided are methods for preventing the horizontal transfer of genetic information between a mobile genetic element and a first cell, cells making use of new genetic codons schemes and related subject matter, kits comprising mutually orthogonal cells, and mobile genetic elements. Also provided are methods of altering the susceptibility of a gene to mutations that alter the encoded amino acid sequence, methods for evolving or improving a protein, and methods for rendering a target gene more resistant to mutation. Additionally provided are uses of the cells for making polymers and methods comprising using the cells for making polymers.

CPC Classifications

C12N 1/20 C12N 1/36 C12N 15/70 C12P 1/04 C12R 2001/19

Filing Date

2023-07-19

Application No.

18993813

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260109938A1

Who this affects

Applies to
Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application Biotechnology research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!